While it is associated with immunosuppression, particularly through inhibition of Th17 cells and modulation of macrophage activity, there is evidence suggesting that IL-10 can also contribute to anti-tumor immune responses under certain conditions (41, 42). The gene discussed is IL10; the disease is neoplasm.